These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22278434)

  • 1. Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism.
    Tomar N; Kaushal E; Das M; Gupta N; Betterle C; Goswami R
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1219-26. PubMed ID: 22278434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
    Alimohammadi M; Björklund P; Hallgren A; Pöntynen N; Szinnai G; Shikama N; Keller MP; Ekwall O; Kinkel SA; Husebye ES; Gustafsson J; Rorsman F; Peltonen L; Betterle C; Perheentupa J; Akerström G; Westin G; Scott HS; Holländer GA; Kämpe O
    N Engl J Med; 2008 Mar; 358(10):1018-28. PubMed ID: 18322283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients.
    Kemp EH; Habibullah M; Kluger N; Ranki A; Sandhu HK; Krohn KJ; Weetman AP
    J Clin Endocrinol Metab; 2014 Mar; 99(3):1064-71. PubMed ID: 24423312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.
    Kemp EH; Kahaly GJ; Porter JA; Frommer L; Weetman AP
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):139-145. PubMed ID: 28941288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody response against NALP5/MATER in primary ovarian insufficiency and in autoimmune Addison's disease.
    Brozzetti A; Alimohammadi M; Morelli S; Minarelli V; Hallgren Å; Giordano R; De Bellis A; Perniola R; Kämpe O; Falorni A;
    J Clin Endocrinol Metab; 2015 May; 100(5):1941-8. PubMed ID: 25734249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the autoimmune regulator gene in patients with autoimmune non-APECED polyendocrinopathies.
    Palma A; Gianchecchi E; Palombi M; Luciano R; Di Carlo P; Crinò A; Cappa M; Fierabracci A
    Genomics; 2013 Sep; 102(3):163-8. PubMed ID: 23643663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.
    Gylling M; Kääriäinen E; Väisänen R; Kerosuo L; Solin ML; Halme L; Saari S; Halonen M; Kämpe O; Perheentupa J; Miettinen A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4602-8. PubMed ID: 14557429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism.
    Goswami R; Gupta N; Ray D; Rani R; Tomar N; Sarin R; Vupputuri MR
    Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism.
    Tomar N; Gupta N; Goswami R
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3884-91. PubMed ID: 23873991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.
    Cervato S; Mariniello B; Lazzarotto F; Morlin L; Zanchetta R; Radetti G; De Luca F; Valenzise M; Giordano R; Rizzo D; Giordano C; Betterle C
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):421-8. PubMed ID: 18616706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
    Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
    Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis.
    Cetani F; Barbesino G; Borsari S; Pardi E; Cianferotti L; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4747-52. PubMed ID: 11600535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients.
    Pöntynen N; Miettinen A; Arstila TP; Kämpe O; Alimohammadi M; Vaarala O; Peltonen L; Ulmanen I
    J Autoimmun; 2006 Sep; 27(2):96-104. PubMed ID: 16820279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.
    Halonen M; Eskelin P; Myhre AG; Perheentupa J; Husebye ES; Kämpe O; Rorsman F; Peltonen L; Ulmanen I; Partanen J
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2568-74. PubMed ID: 12050215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.
    Podkrajsek KT; Bratanic N; Krzisnik C; Battelino T
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4930-5. PubMed ID: 15886230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
    Myhre AG; Halonen M; Eskelin P; Ekwall O; Hedstrand H; Rorsman F; Kämpe O; Husebye ES
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):211-7. PubMed ID: 11207636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.
    Linglart A; Rothenbuhler A; Gueorgieva I; Lucchini P; Silve C; Bougnères P
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3308-12. PubMed ID: 21865375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
    Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
    J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED.
    Cervato S; Morlin L; Albergoni MP; Masiero S; Greggio N; Meossi C; Chen S; del Pilar Larosa M; Furmaniak J; Rees Smith B; Alimohammadi M; Kämpe O; Valenzise M; Betterle C
    Clin Endocrinol (Oxf); 2010 Nov; 73(5):630-6. PubMed ID: 20718774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
    Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
    J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.